Standard of Care: Medication Management and Avoidance
At a Glance
Intranasal corticosteroids are the gold standard treatment for moderate-to-severe allergic rhinitis and should be used daily. Avoid using over-the-counter decongestant sprays for more than 3 to 5 days to prevent severe rebound congestion.
Managing Allergic Rhinitis (AR) effectively requires moving beyond temporary fixes to treatments that address the underlying inflammation. Medical guidelines, such as those from ARIA (Allergic Rhinitis and its Impact on Asthma), recommend a stepped-care approach to ensure you receive the right treatment for your specific severity level [1][2].
Foundational Care: Avoidance and Saline Rinses
Before turning to prescriptions, modifying your environment and employing physical treatments are excellent first steps:
- Trigger Avoidance: Use HEPA filters in your bedroom, apply dust-mite proof covers to your mattress and pillows, and track local pollen counts to minimize exposure [3].
- Saline Rinses: Using a saline rinse or Neti pot (with distilled or boiled water) is a safe, drug-free way to physically wash allergens and excess mucus out of your nasal passages [4].
Mild Symptoms: Oral Antihistamines
If your symptoms are mild or intermittent, the first-line treatment is typically an over-the-counter second-generation oral antihistamine (e.g., cetirizine, loratadine, or fexofenadine) [5].
- A Crucial Warning: Avoid older, first-generation antihistamines like diphenhydramine (Benadryl). These medications cross the blood-brain barrier and cause significant sedation, which will dramatically worsen the “brain fog” and fatigue you may already be experiencing [5].
Moderate-to-Severe: Intranasal Corticosteroids (INCS)
For anyone experiencing moderate-to-severe symptoms, intranasal corticosteroids (INCS) are the gold standard and mainstay of treatment [6][4]. While oral antihistamines are popular, INCS are significantly more effective at reducing the full range of symptoms, including nasal congestion, itching, and runny nose [7][2].
- Why they work better: Unlike antihistamines, which only block histamine, INCS work by calming the overall inflammatory response in the nasal lining [8].
- Consistency is key: These medications work best when used daily and consistently, rather than “as needed,” to keep inflammation under control [4].
Stepping Up: Combination Therapy
If your symptoms are not adequately controlled by a corticosteroid spray alone, your doctor may recommend combination therapy. This typically involves using an INCS along with an intranasal antihistamine (INAH), such as azelastine [6][9]. This combination often provides faster and more comprehensive relief than using either medication by itself [10].
A Warning: Rhinitis Medicamentosa
One of the most common pitfalls in allergy management is the overuse of over-the-counter (OTC) decongestant nasal sprays, such as oxymetazoline (often found in brands like Afrin) [11].
While these sprays provide “instant” relief by shrinking blood vessels, using them for more than 3 to 5 consecutive days can lead to rhinitis medicamentosa—also known as rebound congestion [12][13]. Your nose becomes dependent on the spray, and when it wears off, the swelling returns even worse than before [14].
- The Solution: Treatment involves stopping the decongestant completely, often while starting an INCS to help manage the transition and reduce the rebound swelling [13].
Proper Technique Matters
Using your nasal spray correctly is essential to avoid side effects like nosebleeds (epistaxis) or damage to the septum (the wall dividing your nostrils) [15].
- Preparation: Gently blow your nose to clear the passages.
- Posture: Tilt your head slightly forward, looking down toward the floor (the “nose to toes” posture). This prevents the medication from dripping down the back of your throat.
- Aim Away: Use your right hand to spray into your left nostril, and your left hand for your right nostril. This naturally angles the nozzle away from the center and toward the ear on the same side.
- Avoid the Septum: Never point the nozzle directly at the middle wall of your nose, as the force of the spray can dry out and damage the delicate tissue [16].
- Breathe Gently: You do not need to “snort” the medication; a gentle sniff is enough to keep the medicine in the nasal cavity.
Common questions in this guide
Should I use my nasal corticosteroid spray every day for allergic rhinitis?
What is rhinitis medicamentosa or rebound congestion?
Why should I avoid older antihistamines like Benadryl for my allergies?
How do I correctly use a nasal spray to avoid nosebleeds?
When should I consider combination therapy for my allergies?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Should I be using an intranasal corticosteroid (INCS) daily, even on days when my symptoms feel manageable?
- 2.If my symptoms don't improve with my current spray, at what point should we consider adding an intranasal antihistamine (INAH)?
- 3.Is my current nasal congestion a result of my allergies, or could it be 'rebound' from my previous use of over-the-counter sprays?
- 4.Can you show me the correct way to position the nozzle to avoid damaging my nasal septum?
- 5.Are there specific brands of nasal sprays I should avoid because of the risk of rhinitis medicamentosa?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (16)
- 1
Embedding patients' values and preferences in guideline development for allergic diseases: The case study of Allergic Rhinitis and its Impact on Asthma 2024.
Vieira RJ, Sousa-Pinto B, Bognanni A, et al.
Clinical and translational allergy 2024; (14(6)):e12377 doi:10.1002/clt2.12377.
PMID: 38862272 - 2
[Executive Summary of ARIA 2019: Integrated care pathways for allergic rhinitis in Argentina, Spain and Mexico].
Ivancevich JC, Cardona V, Larenas-Linnemann D, et al.
Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993) 2019; (66(4)):409-425 doi:10.29262/ram.v66i4.643.
PMID: 32105425 - 3
Rhinitis in Primary Care.
Patel N, Bhattacharyya A
Primary care 2025; (52(1)):37-45 doi:10.1016/j.pop.2024.09.006.
PMID: 39939089 - 4
Towards definitive management of allergic rhinitis: best use of new and established therapies.
Hossenbaccus L, Linton S, Garvey S, Ellis AK
Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology 2020; (16()):39 doi:10.1186/s13223-020-00436-y.
PMID: 32508939 - 5
Allergic Rhinitis.
Czech EJ, Overholser A, Schultz P
Primary care 2023; (50(2)):159-178 doi:10.1016/j.pop.2023.01.003.
PMID: 37105599 - 6
Update on pediatric allergic rhinitis: narrative review based on guideline updates.
Shim JY
Clinical and experimental pediatrics 2026; (69(6)):473-483 doi:10.3345/cep.2026.00444.
PMID: 42208600 - 7
Intranasal corticosteroids compared with oral antihistamines in allergic rhinitis: A systematic review and meta-analysis.
Juel-Berg N, Darling P, Bolvig J, et al.
American journal of rhinology & allergy 2017; (31(1)):19-28 doi:10.2500/ajra.2016.30.4397.
PMID: 28234147 - 8
Allergic Rhinitis: an Overview.
Varshney J, Varshney H
Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India 2015; (67(2)):143-9 doi:10.1007/s12070-015-0828-5.
PMID: 26075169 - 9
A Comparative Study of Montelukast and Azelastine add on Therapy in Moderate to Severe Allergic Rhinitis Treatment: A Double-Blind Randomized Clinical Trial.
Esmaeilzadeh H, Far NM, Nabavizadeh SH, et al.
American journal of rhinology & allergy 2022; (36(5)):559-567 doi:10.1177/19458924221086268.
PMID: 35300506 - 10
Combination therapy in allergic rhinitis: What works and what does not work.
Greiwe JC, Bernstein JA
American journal of rhinology & allergy 2016; (30(6)):391-396 doi:10.2500/ajra.2016.30.4391.
PMID: 28124648 - 11
Severe nasal spray oxymetazoline use disorder - a case report.
Podwojniak AC, Chen K, Pullinger B, et al.
Journal of addictive diseases 2026; (44(1)):96-100 doi:10.1080/10550887.2024.2430072.
PMID: 39930799 - 12
The prevalence of non-allergic rhinitis phenotypes in the general population: A cross-sectional study.
Avdeeva KS, Fokkens WJ, Segboer CL, Reitsma S
Allergy 2022; (77(7)):2163-2174 doi:10.1111/all.15223.
PMID: 35038765 - 13
Rhinitis medicamentosa: a nationwide survey of Canadian otolaryngologists.
Fowler J, Chin CJ, Massoud E
Journal of otolaryngology - head & neck surgery = Le Journal d'oto-rhino-laryngologie et de chirurgie cervico-faciale 2019; (48(1)):70 doi:10.1186/s40463-019-0392-1.
PMID: 31818321 - 14
Does nose spray addiction exist? A qualitative analysis of addiction components in rhinitis medicamentosa.
Lakatos L, Koltai BG, Ferencz V, et al.
Journal of behavioral addictions 2025; (14(1)):548-560 doi:10.1556/2006.2024.00078.
PMID: 39932504 - 15
Epistaxis Risk Associated with Intranasal Corticosteroid Sprays: A Systematic Review and Meta-analysis.
Wu EL, Harris WC, Babcock CM, et al.
Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 2019; (161(1)):18-27 doi:10.1177/0194599819832277.
PMID: 30779679 - 16
Nasal Septal Perforation Due to Desmopressin Nasal Spray Use.
Brake DA, Hamilton GS, Bansberg SF
Ear, nose, & throat journal 2023; (102(12)):NP621-NP624 doi:10.1177/01455613211026425.
PMID: 34233494
This page provides educational information about allergic rhinitis treatments and medication management. Always consult your doctor or allergist before starting or stopping any medications.
Get notified when new evidence is published on allergic rhinitis.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.